Loading organizations...
Loading organizations...
Developing drugs to restore liver regeneration in chronic diseases.
HepaRegeniX has raised $63.2M across 4 funding rounds.
HepaRegeniX has raised $63.2M in total across 4 funding rounds.
HepaRegeniX has raised $63.2M in total across 4 funding rounds.
HepaRegeniX's investors include Vesalius Biocapital.
HepaRegeniX has raised $63.2M across 4 funding rounds. Most recently, it raised $25.3M Other Equity in April 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Apr 15, 2025 | $25.3M Other Equity | ||
| Jul 10, 2024 | $16.2M Series C | Vesalius Biocapital | |
| Jan 24, 2020 | $12.2M Series B | ||
| Jan 6, 2017 | $9.5M Series A |